As per the collaboration, the companies will provide Single Sign-On (SSO) and Federated-Authentication access to eClinical applications used to support clinical trials, including Interactive Response Technology (IRT).
According to Almac, the SSO functionality eliminates the need for site personnel and patients to maintain multiple credentials.
Charlie Morris, Vice President, New Products and Services, Almac Clinical Technologies told us the company foresees centralized, cloud-based credential management as emerging as “the de facto method for sponsors to safeguard their intellectual property by applying industry standard best practices to the integration of their insourced and outsourced clinical trial applications.”
Integrating with other applications within the eClinical spectrum, such as clinical trial management, LIMS, EDC, allows Almac to add value to sponsors by ensuring that data transfers and other integration is seamless, “thus ensuring the integrity of their data and reduces risk to the clinical trial,” he added.
Morris explained managing user credentials is difficult problem for sponsors, since providing access to the applications which comprise the eClinical spectrum exposes intellectual property to risk.
“A single source of user access provisioning and deprovisioning affords sponsors a new level of control over who has access to their data as well as how quickly and reliably that access can be granted and revoked,” he said.
Earlier this month Almac also announced a strategic partnership with the contract research organization (CRO) inVentiv Health. The partnership allows both companies to provide clients and site with streamlined access to clinical trial Interactive Response Technology (IRT) solutions.
Following both announcements, Morris told us the company will continue to identify strategic partners like Exostar where collaboration will produce “clear and tangible benefits to our customers.”